KOTRA: Kotra Industries Berhad - Summary | Jitta

Kotra Industries Berhad

MAL:KOTRA

Price
RM3.82
Loss Chance
49.2%
4.54JITTA SCORE
109.24%Over Jitta Line
Jitta Ranking
775 / 1,004
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (28)
Recent Business Performance (43)
Financial Strength (94)
Return to Shareholders (51)
Competitive Advantage (40)
Jitta Signs
Debt LevelLow Long Term Debt
Interest Coverage RatioVery Good
Revenue and EarningEarning decline from 2022-2025
Recent Business PerformanceEarning decline 32.21% in the last quarter (yoy)
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
4.54
109.24%
5.13
129.18%
3.68
135.70%
Pharmaceuticals
6.10
17.36%
3.28
500.97%
6.59
27.11%
COMPANY DESCRIPTION
Kotra Industries Berhad, an investment holding company, develops, manufactures, and trades in pharmaceutical and healthcare products in Malaysia. The company provides nutraceutical products, including various health supplement products under the Appeton brand for children, expectant mothers, and senior citizens. It also offers various pharmaceutical products in the areas of pediatric care, anti-infective, gastroenterology, and dermatology under the Axcel brand; sterile antibiotic injectables under the Vaxcel brand; asthma control products under the Arite brand; and fungal infection treatment products under the Creobic brand. In addition, it provides treatment of pain, such as fever, migraine, joint pain, headache, and backpain under the AxPain brand. The company was founded in 1982 and is headquartered in Malacca, Malaysia. Kotra Industries Berhad is a subsidiary of Piong Nam Kim Holdings Sdn. Bhd.